|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01652 FUSEN PHARM
Nominal 
0.800 0.000 (0.000%) | 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/12 RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | |
| Turnover | 114,058 | 2.491% | 273,365 | 326,029 | 565,608 | 491,757 |
| Cost of Sales | (64,938) | -4.917% | (163,577) | (163,392) | (266,102) | (266,736) |
| Gross Profit | 49,120 | 14.259% | 109,788 | 162,637 | 299,506 | 225,021 |
| 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/12 RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | (9,657) | -- | (25,938) | (9,081) | -- | (38,007) | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 424 | -91.977% | 14,453 | (104,097) | (40,621) | (21,019) | |
| Profit / (Loss) before Taxation | (13,574) | -40.268% | (7,603) | (190,446) | (29,448) | (30,993) | |
| Taxation | (100) | -75.669% | (4,198) | 1,646 | (6,847) | (3,661) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 0 | -- | 17 | 17 | 18 | 49 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (13,674) | -40.897% | (11,784) | (188,783) | (36,277) | (34,605) | |
| 2026/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2025/12 RMB(K¥) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | |
| Net Finance Costs / (Income) | 8,293 | 6.103% | 20,335 | 18,838 | 8,843 | 15,725 |
| Depreciation & Amortisation | -- | -- | 13,744 | 41,711 | 35,798 | 34,161 |
| Directors' Emoluments | -- | -- | -- | 2,702 | 5,769 | 2,580 |
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/12 | 2024/12 | 2023/12 | 2022/12 | |
| Auditor's Opinion Status | N/A | -- | Unqualified (Modified Report) | Unqualified (Modified Report) | Unqualified | Unqualified |
Market Valuation Indicators
| 2026/06 - Interim | %Chg (Compare to Interim) | 2025/12 | 2024/12 | 2023/12 | 2022/12 | |
| EPS (cts) | -1.840 | -41.214% | -1.590 | -25.500 | -5.000 | -5.000 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | 0.169 | 0.181 | (0.027) | 0.146 |
| NBV per share ($) | 0.467 | -- | 0.486 | 0.500 | 0.751 | 0.810 |
| Remarks: | Real time quote last updated: 11/09/2026 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB -13,674 |
| %Change | -40.897% |
| EPS / (LPS) | RMB -0.018 |
| NBV Per Share (¥) | RMB 0.467 |